Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Segment revenue | revenue | 711.12M | 6.97% |
| Operating income (loss) from continuing operations | profit | 75.89M | 5.06% |
| Cost of product and service sold | cost | 323.46M | 11.84% |
| Selling, general and administrative expenses | cost | 253.88M | 1.67% |
| Research and development expenses | cost | 57.89M | 8.00% |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | profit | 49.99M | -4.56% |
| Interest and other expense net | cost | 25.89M | 30.46% |
| Income from continuing operations | profit | 40.89M | -1.86% |
| Provision for income taxes | cost | 9.10M | -15.07% |
| Net income | profit | 40.72M | -3.60% |
| Income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest | revenue | 175000 | -69.19% |
| Segment | Value | YoY |
|---|---|---|
| Life Sciences | 361.85M | 6.30% |
| Diagnostics | 349.27M | 7.68% |
| Segment | Value | YoY |
|---|---|---|
| Americas | 315.99M | 3.73% |
| Europe | 223.05M | 22.69% |
| Asia | 172.08M | -3.51% |
| Segment | Value | YoY |
|---|---|---|
| Product | 581.46M | 3.34% |
| Service | 129.66M | 27.02% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Cash and cash equivalents | assets | 860.32M | |
| Accounts receivable, net | assets | 691.38M | |
| Inventories, net | assets | 387.50M | |
| Other current assets | assets | 189.11M | |
| Total current assets | assets | 2.13B | |
| Goodwill | assets | 6.61B | |
| Intangible assets, net | assets | 2.31B | |
| Property, plant and equipment, net | assets | 465.64M | |
| Other assets, net | assets | 322.10M | |
| Operating lease, right-of-use asset | assets | 163.25M | |
| Total assets | assets | 12.00B | |
| Total liabilities | liabilities | 4.81B | |
| Total stockholders’ equity | equity | 7.18B | |
| Accumulated other comprehensive loss | equity | 253.56M | |
| Long-term debt | liabilities | 2.63B | |
| Total current liabilities | liabilities | 1.24B | |
| Deferred taxes and other long-term liabilities | liabilities | 800.86M | |
| Operating lease, liability, noncurrent | liabilities | 142.28M | |
| Aggregate | equity | 7.44B | |
| Current portion of long-term debt | liabilities | 575.83M | |
| Accrued expenses and other current liabilities | liabilities | 493.13M | |
| Accounts payable | liabilities | 169.68M | |
| Retained earnings | equity | 6.09B | |
| Capital in excess of par value | equity | 1.24B | |
| Common stock, value, issued | equity | 111.63M |
| Item | Value |
|---|---|
| Net cash provided by operating activities of continuing operations | 125.89M |
| Depreciation and amortization | 105.06M |
| Increase (decrease) in accounts receivable | 61.55M |
| Income from continuing operations | 40.89M |
| Restructuring and other costs | 10.68M |
| Stock-based compensation | 8.71M |
| Change in fair value of financial securities | 4.20M |
| Amortization of debt issuance costs and discounts | 1.14M |
| Unrealized gain (loss), foreign currency transaction, before tax | 100000 |
| Business combination, contingent consideration, change in contingent consideration, liability, increase (decrease) | -99000 |
| Gain (loss) on disposition of business | -5.07M |
| Net cash used in operating activities of discontinued operations | -10.66M |
| Increase (decrease) in inventories | -12.84M |
| Accounts payable | -13.74M |
| Increase (decrease) in accrued expenses and other | -74.69M |
| Item | Value |
|---|---|
| Proceeds from disposition of property, plant and equipment | 9.00M |
| Proceeds from investments and notes receivables | 677000 |
| Proceeds from disposition of businesses and assets | 158000 |
| Purchases of investments and notes receivables | -1.05M |
| Payments to acquire property, plant, and equipment | -19.77M |
| Payments for acquisitions and investments, net of cash and cash equivalents acquired | -67.28M |
| Net cash used in investing activities of continuing operations | -78.27M |
| Item | Value |
|---|---|
| Proceeds from issuance of common stock under stock plans | 5.44M |
| Payments of ordinary dividends, common stock | -7.84M |
| Payments for repurchase of common stock | -86.50M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 921.03M |
| Cash and cash equivalents, end of period | 861.47M |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support